| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 20.09× | 20.09× | 22.47× | 15.72× | 11.00× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.64× | 1.68× | 1.82× | 1.65× | 1.73× | ||
| 0.89× | 0.89× | 0.94× | 0.90× | 1.08× | ||
| 1.24× | 1.24× | 1.03× | 1.14× | 1.12× | ||
| 0.85× | 0.85× | 0.73× | 0.80× | 0.76× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 11.00 | 15.72 | 22.47 | 20.09 | 20.09 | |
| Working Capital Turnover | 1.73 | 1.65 | 1.82 | 1.68 | 1.64 | |
| Asset Turnover | 1.08 | 0.90 | 0.94 | 0.89 | 0.89 | |
| Cash Conversion (CFO/Net Income) | 1.12 | 1.14 | 1.03 | 1.24 | 1.24 | |
| CFO/EBITDA | 0.76 | 0.80 | 0.73 | 0.85 | 0.85 |